Funder: Crohn's and Colitis Foundation
Due Dates: To be determined (check program page for updates)
Funding Amounts: Up to $1,500,000 total per project over three years; most funds support CRO-led preclinical development
Summary: Supports academic researchers in translating novel, validated drug targets for Crohn’s disease and ulcerative colitis into preclinical therapeutic opportunities.
Key Information: Most research is performed at a contract research organization (CRO) with active Foundation guidance.